Insider cluster buying post-earnings suggests the recall is viewed as manageable and the 122% revenue growth trajectory is intact. Monitor for FDA approval of original CGuard delivery system (expected Q3 2026) and resolution of the 135 cm recall — both could serve as catalysts. The CEO's personal purchase alongside directors reinforces bullish conviction.
Price Chart
Executive Summary
Four InspireMD insiders, including CEO Marvin Slosman and three directors, collectively purchased $227K in open-market shares over a one-week period following the company's Q1 2026 earnings release. The buys represent ~0.43% of market cap and signal management's confidence despite a voluntary recall of CGuard Prime 135 cm and a net loss of $13.7M.
Key Financial Metrics
Key Facts
- 4 insiders purchased $227K in open-market shares (May 6–13, 2026)
- CEO Marvin Slosman bought 21,000 shares at $1.20 ($25K)
- Director Gary S. Roubin bought 90,000 shares at $1.18 ($106K)
- Director Scott R. Ward bought 73,300 shares at $1.15 ($84K)
- Director Paul Stuka bought 10,000 shares at $1.16 ($12K)
- Cluster follows Q1 2026 earnings: revenue $3.4M (+122% YoY), net loss $13.7M ($0.16/share)
- Voluntary recall of CGuard Prime 135 cm delivery system reserved $1.35M in costs
Financial Impact
$227K insider purchases (0.43% of $53M market cap)
Risk Factors
- Voluntary recall of CGuard Prime 135 cm may dampen near-term U.S. sales
- Net loss widening to $13.7M in Q1 2026 from $11.2M a year ago
- Small market cap ($53M) amplifies stock volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NSPR-1778875774219 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | 8-K | $0.7500 $0.6895 | ▼ −8.07% | ▼ −7.05% | $0.4500 (−40.00%) |
Sep 21, 2026 5w ago | Press Release | $0.7500 $0.6895 | ▼ −8.07% | ▼ −7.05% | $0.4500 (−40.00%) |
Aug 17, 2026 10w ago | 8-K | $0.8798 $0.8699 | ▲ +1.13% | ▼ −0.07% | $0.4500 (+48.85%) |
Aug 17, 2026 10w ago | Press Release | $0.8798 $0.8699 | ▲ +1.13% | ▼ −0.07% | $0.4500 (+48.85%) |
Aug 10, 2026 11w ago | Press Release | $0.8500 $0.8816 | ▲ +3.72% | ▲ +4.12% | $0.4500 (−47.06%) |
Jul 29, 2026 12w ago | 8-K | $0.6718 $0.7222 | ▲ +7.50% | ▲ +3.88% | $0.4500 (−33.02%) |
Jul 23, 2026 13w ago | 8-K | $0.6835 $0.6718 | ▲ +1.71% | ▲ +2.09% | $0.4500 (+34.16%) |
Jul 2, 2026 16w ago | 8-K | $0.6990 $0.7121 | ▲ +1.87% | ▲ +0.94% | $0.4500 (−35.62%) |
May 21, 2026 22w ago | Insider Cluster | $1.00 $0.9900 | ▼ −1.00% | ▼ −2.66% | $0.4500 (−55.00%) |
May 15, 2026 23w ago | Insider Cluster | $1.05 $0.9500 | ▼ −9.52% | ▼ −11.14% | $0.4500 (−57.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers